These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35523321)

  • 1. Systematic review on fecal calprotectin in cystic fibrosis.
    Lazzarotto ES; Vasco JFM; Führ F; Riedi CA; Filho NAR
    J Pediatr (Rio J); 2023; 99(1):4-10. PubMed ID: 35523321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children.
    Garg M; Leach ST; Coffey MJ; Katz T; Strachan R; Pang T; Needham B; Lui K; Ali F; Day AS; Appleton L; Moeeni V; Jaffe A; Ooi CY
    J Cyst Fibros; 2017 Sep; 16(5):631-636. PubMed ID: 28416415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis.
    Fallahi G; Motamed F; Yousefi A; Shafieyoun A; Najafi M; Khodadad A; Farhmand F; Ahmadvand A; Rezaei N
    Turk J Pediatr; 2013; 55(5):475-8. PubMed ID: 24382526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calprotectin in cystic fibrosis.
    Rumman N; Sultan M; El-Chammas K; Goh V; Salzman N; Quintero D; Werlin S
    BMC Pediatr; 2014 May; 14():133. PubMed ID: 24885444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?
    Pang T; Leach ST; Katz T; Jaffe A; Day AS; Ooi CY
    J Gastroenterol Hepatol; 2015 May; 30(5):866-71. PubMed ID: 25376228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe disease in Cystic Fibrosis and fecal calprotectin levels.
    Parisi GF; Papale M; Rotolo N; Aloisio D; Tardino L; Scuderi MG; Di Benedetto V; Nenna R; Midulla F; Leonardi S
    Immunobiology; 2017 Mar; 222(3):582-586. PubMed ID: 28012584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal inflammation and impact on growth in children with cystic fibrosis.
    Dhaliwal J; Leach S; Katz T; Nahidi L; Pang T; Lee JM; Strachan R; Day AS; Jaffe A; Ooi CY
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):521-6. PubMed ID: 25539196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response?
    Ooi CY; Pang T; Leach ST; Katz T; Day AS; Jaffe A
    Dig Dis Sci; 2015 Oct; 60(10):2946-52. PubMed ID: 26271615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of fecal calprotectin and respiratory exacerbation in cystic fibrosis patients.
    Imanzadeh F; Kerami F; Hassanzad M; Hosseini A; Hajipour M; Khanbabaee G; Dara N; Khatami K; Farahbakhsh N; Sayyari A
    BMC Gastroenterol; 2022 Nov; 22(1):494. PubMed ID: 36443671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis.
    Lisowska A; Madry E; Pogorzelski A; Szydłowski J; Radzikowski A; Walkowiak J
    Scand J Clin Lab Invest; 2010 Sep; 70(5):322-6. PubMed ID: 20560844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial.
    López-Neyra A; Suárez L; Muñoz M; de Blas A; Ruiz de Valbuena M; Garriga M; Calvo J; Ribes C; Girón Moreno R; Máiz L; González D; Bousoño C; Manzanares J; Pastor Ó; Martínez-Botas J; Del Campo R; Cantón R; Roy G; Menacho M; Arroyo D; Zamora J; Soriano JB; Lamas A
    Prostaglandins Leukot Essent Fatty Acids; 2020 Nov; 162():102186. PubMed ID: 33038833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics for people with cystic fibrosis.
    Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
    Konikoff MR; Denson LA
    Inflamm Bowel Dis; 2006 Jun; 12(6):524-34. PubMed ID: 16775498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Calprotectin in Cystic Fibrosis and Its Relation to Disease Parameters: A Longitudinal Analysis for 12 Years.
    Ellemunter H; Engelhardt A; Schüller K; Steinkamp G
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):438-442. PubMed ID: 28207476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calprotectin, an available prognostic biomarker in systemic sclerosis: a systematic review.
    Ebrahimi B; Nazarinia M; Molayem M
    Clin Rheumatol; 2021 May; 40(5):1709-1715. PubMed ID: 33044726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin concentrations in young children with cystic fibrosis: Authors response.
    Garg M; Leach ST; Day AS; Ooi CY
    J Cyst Fibros; 2018 Jan; 17(1):e10-e11. PubMed ID: 29128316
    [No Abstract]   [Full Text] [Related]  

  • 17. Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial.
    Scaioli E; Belluzzi A; Ricciardiello L; Del Rio D; Rotondo E; Mena P; Derlindati E; Danesi F
    Trials; 2019 Jun; 20(1):327. PubMed ID: 31171016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Fecal Calprotectin Levels in Cystic Fibrosis Patients After Antibiotic Treatment for Respiratory Exacerbation.
    Schnapp Z; Hartman C; Livnat G; Shteinberg M; Elenberg Y
    J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):282-284. PubMed ID: 30640865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.
    Flass T; Tong S; Frank DN; Wagner BD; Robertson CE; Kotter CV; Sokol RJ; Zemanick E; Accurso F; Hoffenberg EJ; Narkewicz MR
    PLoS One; 2015; 10(2):e0116967. PubMed ID: 25658710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal Symptoms Assessed With the CFAbd-Score are Associated With Intestinal Inflammation in Patients With Cystic Fibrosis.
    Jaudszus A; Pfeifer E; Lorenz M; Beiersdorf N; Hipler UC; Zagoya C; Mainz JG
    J Pediatr Gastroenterol Nutr; 2022 Mar; 74(3):355-360. PubMed ID: 34789668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.